Ewing's sarcoma and primitive neuroectodermal tumours in adults: Single-centre experience in the Netherlands

Netherlands Journal of Medicine

Volumn 65, Issue 4, 2007, Pages 132-136

  Smorenburg, C H ^a,b   Van Groeningen, C J ^a   Meijer, O W M ^a   Visser, M ^a   Boven, E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

Author keywords

Adults; Ewing's sarcoma; PNET

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TOXICITY; BONE METASTASIS; CANCER GROWTH; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EWING SARCOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUNG METASTASIS; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NETHERLANDS; NEUROECTODERM TUMOR; NEUTROPENIA; OVERALL SURVIVAL; PATIENT REFERRAL; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 34247540334     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rodriquez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol 2003;40:276-87.
2. Arndt CAS, Crist WM. Common muskuloskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342-52.
3. Delattre O, Zucman J, Melot T, et al. The Ewing-family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-9.
4. mic2. Am J Pathol 1991;139:317-25.
5. Downing JR, Head DR, Parham DM, et al. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol 1993;143:1294-300.
6. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transciption factor, ERG. Nat Genet 1994;6:146-51.
7. Torchia EC, Jaishankar S, Baker SJ. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res 2003;63:3464-8.
8. Sinkovics JG, Plager C, Ayala AG, Lindberg RD, Samuels ML. Ewing sarcoma: its course and treatment in 50 adult patients. Oncology 1980;37:114-9.
9. Verrill MW, Judson IR, Harmer CL, Fisher C, Thomas JM, Wiltshaw E. Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? J Clin Oncol 1997;15:2611-21.
10. Fizazi K, Dohollou N, Blay JY, et al. Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol 1998;16:3736-43.
11. Baldini EH, Demetri GD, Fletcher CDM, Foran J, Marcus KC, Singer S. Adults with Ewing's sarcoma/primitive neuroectodermal tumor. Ann Surgery 1999;230:79-86.
12. Bacci G, Ferrari S, Comandone A, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol 2000;39:111-6.
13. Martin RCG, Brennan MF. Adult soft tissue Ewing Sarcoma or primitive neuroectodermal tumors: predictors of survival? Arch Surg 2003;138:281-5.
14. Laurence V, Pierga JY, Barthier S, et al. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing sarcoma. Am J Clin Oncol 2005;28:301-9.
15. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS-86. J Clin Oncol 2001;19:1818-29.
16. Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003;55:168-77.
17. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701.
18. Paulussen M, Ahrens 5, Burdach S, et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. Ann Oncol 1998;9:275-81.
19. Paulussen M, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Proc Am Soc Clin Oncol 2003;22:816 (abstract 3279).
20. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108-14.
21. Miser JS, Krailo MD, Tarbell NJ, et al. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide-a Children's Cancer Group and Pediatric Oncology Group Study. J Clin Oncol 2004;22:2873-6.
22. Pinkerton CR. Bataillard A, Guilo S, Oberlin O, Fervers B, Philip T. Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer 2001;37:1338-44.
23. Burdach S, Meyer-Bahlburg A, Laws HJ, et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 2003;21:3072-8.
24. Schleiermacher G, Peter M, Oberlin O, et al. Increased risk of systemic relapses associated with bone marrow micrometastases and circulating tumor cells in localized Ewing tumor. J Clin Oncol 2003;21:85-91.